comparemela.com

Latest Breaking News On - Dry eye center - Page 2 : comparemela.com

New Jersey Vision Associates Announces New Location in the Bloomfield Community

BLOOMFIELD, N.J. (PRWEB) February 24, 2022 Mitchell Vogel, M.D., F.A.C.S., announces New Jersey Vision Associates’ new office is now open at 1455 Broad

SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease

SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease ProGIFT is a 3 arms, multicenter, randomized, double-masked clinical trial in Italy. CATANIA, Italy, April 27, 2021 /PRNewswire/ SIFI announced today the enrollment of the first patients in the ProGIFT trial (NCT04645446), which aims at evaluating the safety and efficacy of Pro-ocular, a progesterone based topical gel in patients with Dry Eye Disease (DED). ProGIFT (NCT04645446) is a multicenter, randomized, double-masked, placebo-controlled Phase II clinical trial comparing different concentrations of Pro-ocular (1% and 0.5%) versus placebo. The trial involves 4 leading ophthalmic centers in Italy specialized on disorders of the ocular surface and is expected to recruit 105 participants.

First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr Art Epstein

First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr Art Epstein
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Regener Eyes: First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr Art Epstein

(1) PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes ®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board. We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company s efforts, commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes ®. We are honored to add Dr. Epstein to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter and Dr. Ahmed Fahmy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.